FCGR2A and lung carcinoma: These findings validate CD47 is still one of the most crucial brakes on phagocytosis in lung cancer, and that a therapeutic strategy combining blockade of the “don't eat me” signal (CD47) with boosting both “eat me” signals (Fc‐FcγR and ecto‐CRT) is a feasible way to maximize the macrophage clearance in cancer cells.[62]